Allogeneic, donor-derived, second-generation, CD19-directed CAR-T cells for the treatment of pediatric relapsed/refractory BCP-ALL

被引：38

作者：

del Bufalo, Francesca ^{[1
]}

Becilli, Marco ^{[1
]}

Rosignoli, Chiara ^{[1
]}

De Angelis, Biagio ^{[1
]}

Algeri, Mattia ^{[1
]}

Hanssens, Linda ^{[2
]}

Gunetti, Monica ^{[3
]}

Iacovelli, Stefano ^{[3
]}

Li Pira, Giuseppina ^{[1
]}

Girolami, Elia ^{[1
]}

Leone, Giovanna ^{[4
]}

Lazzaro, Stefania ^{[4
]}

Bertaina, Valentina ^{[1
]}

Sinibaldi, Matilde ^{[1
]}

Di Cecca, Stefano ^{[1
]}

Iaffaldano, Laura ^{[1
]}

Kunkele, Annette ^{[5
,6
,7
]}

Boccieri, Emilia ^{[1
]}

Del Baldo, Giada ^{[1
]}

Pagliara, Daria ^{[1
]}

Merli, Pietro ^{[1
]}

Carta, Roberto ^{[1
]}

Quintarelli, Concetta ^{[1
,8
]}

Locatelli, Franco ^{[1
,9
,10
]}

机构：

[1] Bambino Gesu Pediat Hosp, Ist Ricovero & Cura Carattere Sci IRCCS, Dept Hematol Oncol Cell & Gene Therapy, Rome, Italy

[2] Miltenyi Biomed, Bergisch Gladbach, Germany

[3] Good Mfg Practice Facil, Officina Farmaceut, Rome, Italy

[4] Bambino Gesu Pediat Hosp, Dept Labs, Transfus Unit, IRCCS, Rome, Italy

[5] Charite Univ med Berlin, Dept Pediat Oncol & Hematol, Berlin, Germany

[6] Humboldt Univ, Freie Univ Berlin, Berlin, Germany

[7] Berlin Inst Hlth, Berlin, Germany

[8] Univ Naples Federico II, Dept Clin Med & Surg, Naples, Italy

[9] Univ Cattolica Sacro Cuore, Dept Life Sci & Publ Hlth, Rome, Italy

[10] Bambino Gesu Pediat Hosp, Dept Hematol Oncol Cell & Gene Therapy, IRCCS, Piazza S Onofrio 4, I-00165 Rome, Italy

来源：

BLOOD | 2023年 / 142卷 / 02期

关键词：

ACUTE LYMPHOBLASTIC-LEUKEMIA; TRANSPLANTATION;

D O I：

10.1182/blood.2023020023

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Autologous CD19-directed chimeric antigen receptor (CAR)-T cells have shown unprecedented efficacy in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia (BCP-ALL). However, patients either relapsing after allogeneic hematopoietic stem cell transplantation (allo-HSCT) or displaying profound lymphopenia and/or rapidly progressing disease often cannot access autologous products. These hurdles may be overcome by allogeneic, donor-derived CAR-T cells. We tested donor-derived T cells transduced with a second-generation (4.1BB) CD19-directed CAR for treatment of patients with BCP-ALL in a hospital-exemption setting. Two constructs were tested: a retroviral construct incorporating the suicide gene inducible caspase-9 (CD19-CAR- Retro_ALLO) first and then a lentiviral construct and an automated, Prodigy-based manufacturing process (CD19-CAR-Lenti_ALLO). Thirteen children/young adults received ALLO-CAR-T cells between March 2021 and October 2022. Doses ranged between 1.0 x 10(6) and 3.0 x 10(6) CAR-T cells per kg. The toxicity profile was comparable with that of autologous CAR-T cells, characterized mainly by cytopenia, cytokine release syndrome (maximum grade 1), and grade 2 immune-effector cell-associated neurotoxicity syndrome. One case of acute graft-versus-host disease (GVHD) occurred and was rapidly controlled with steroids and ruxolitinib. None of the other patients, including 3 given ALLO-CAR-T cells from an HLA-haploidentical donor, experienced GVHD. Two patients received ALLO-CAR-T cells before HSCT and showed a significant expansion of CAR-T cells without any sign of GVHD. All patients obtained complete remission (CR) with absence of minimal residual disease in the bone marrow. With a median follow-up of 12 months (range, 5-21), 8 of 13 patients maintained CR. Allogeneic anti-CD19 CAR-T cells can effectively treat highly refractory BCP-ALL relapsing after allo-HSCT without showing increased toxicity as compared with autologous CAR-T cells.

引用

页码：146 / 157

页数：12

共 30 条

[1]

Anagnostou T, 2020, LANCET HAEMATOL, V7, pE816, DOI 10.1016/S2352-3026(20)30277-5

[2] CAR T cell manufacturing from naive/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome [J].

Arcangeli, Silvia ;

Bove, Camilla ;

Mezzanotte, Claudia ;

Camisa, Barbara ;

Falcone, Laura ;

Manfredi, Francesco ;

Bezzecchi, Eugenia ;

El Khoury, Rita ;

Norata, Rossana ;

Sanvito, Francesca ;

Ponzoni, Maurilio ;

Greco, Beatrice ;

Moresco, Marta Angiola ;

Carrabba, Matteo G. ;

Ciceri, Fabio ;

Bonini, Chiara ;

Bondanza, Attilio ;

Casucci, Monica .

JOURNAL OF CLINICAL INVESTIGATION, 2022, 132 (12)

[3] CD19 CAR T cells are an effective therapy for posttransplant relapse in patients with B-lineage ALL: real-world data from Germany [J].

Bader, Peter ;

Rossig, Claudia ;

Hutter, Martin ;

Ayuk, Francis Ayuketang ;

Baldus, Claudia D. ;

Buecklein, Veit L. ;

Bonig, Halvard ;

Cario, Gunnar ;

Einsele, Hermann ;

Holtick, Udo ;

Koenecke, Christian ;

Bakhtiar, Shahrzad ;

Kuenkele, Annette ;

Meisel, Roland ;

Mueller, Fabian ;

Mueller, Ingo ;

Penack, Olaf ;

Rettinger, Eva ;

Sauer, Martin G. ;

Schlegel, Paul -Gerhardt ;

Soerensen, Jan ;

von Stackelberg, Arend ;

Strahm, Brigitte ;

Hauer, Julia ;

Feuchtinger, Tobias ;

Jarisch, Andrea .

BLOOD ADVANCES, 2023, 7 (11) :2436-2448

[4] Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies [J].

Benjamin, Reuben ;

Graham, Charlotte ;

Yallop, Deborah ;

Jozwik, Agnieszka ;

Mirci-Danicar, Oana C. ;

Lucchini, Giovanna ;

Pinner, Danielle ;

Jain, Nitin ;

Kantarjian, Hagop ;

Boissel, Nicolas ;

Maus, Marcela V. ;

Frigault, Matthew J. ;

Baruchel, Andre ;

Mohty, Mohamad ;

Gianella-Borradori, Athos ;

Binlich, Florence ;

Balandraud, Svetlana ;

Vitry, Fabien ;

Thomas, Elisabeth ;

Philippe, Anne ;

Fouliard, Sylvain ;

Dupouy, Sandra ;

Marchiq, Ibtissam ;

Almena-Carrasco, Maria ;

Ferry, Nicolas ;

Arnould, Sylvain ;

Konto, Cyril ;

Veys, Paul ;

Qasim, Waseem .

LANCET, 2020, 396 (10266) :1885-1894

[5] HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia [J].

Bonini, C ;

Ferrari, G ;

Verzeletti, S ;

Servida, P ;

Zappone, E ;

Ruggieri, L ;

Ponzoni, M ;

Rossini, S ;

Mavilio, F ;

Traversari, C ;

Bordignon, C .

SCIENCE, 1997, 276 (5319) :1719-1724

[6] Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease [J].

Brudno, Jennifer N. ;

Somerville, Robert P. T. ;

Shi, Victoria ;

Rose, Jeremy J. ;

Halverson, David C. ;

Fowler, Daniel H. ;

Gea-Banacloche, Juan C. ;

Pavletic, Steven Z. ;

Hickstein, Dennis D. ;

Lu, Tangying L. ;

Feldman, Steven A. ;

Iwamoto, Alexander T. ;

Kurlander, Roger ;

Maric, Irina ;

Goy, Andre ;

Hansen, Brenna G. ;

Wilder, Jennifer S. ;

Blacklock-Schuver, Bazetta ;

Hakim, Frances T. ;

Rosenberg, Steven A. ;

Gress, Ronald E. ;

Kochenderfer, James N. .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (10) :1112-+

[7] Donor-derived CD19-targeted T cell infusion induces minimal residual disease-negative remission in relapsed B-cell acute lymphoblastic leukaemia with no response to donor lymphocyte infusions after haploidentical haematopoietic stem cell transplantation [J].

Chen, Yuhong ;

Cheng, Yifei ;

Suo, Pan ;

Yan, Chenhua ;

Wang, Yu ;

Chen, Yao ;

Han, Wei ;

Xu, Lanping ;

Zhang, Xiaohui ;

Liu, Kaiyan ;

Chang, Lungji ;

Xiao, Lei ;

Huang, Xiaojun .

BRITISH JOURNAL OF HAEMATOLOGY, 2017, 179 (04) :598-605

[8] Tolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemia [J].

Dai, Hanren ;

Zhang, Wenying ;

Li, Xiaolei ;

Han, Qingwang ;

Guo, Yelei ;

Zhang, Yajing ;

Wang, Yao ;

Wang, Chunmeng ;

Shi, Fengxia ;

Zhang, Yan ;

Chen, Meixia ;

Feng, Kaichao ;

Wang, Quanshun ;

Zhu, Hongli ;

Fu, Xiaobing ;

Li, Suxia ;

Han, Weidong .

ONCOIMMUNOLOGY, 2015, 4 (11)

[9] B-cell depleting immunotherapies: therapeutic opportunities and toxicities [J].

Del Bufalo, Francesca ;

Merli, Pietro ;

Alessi, Iside ;

Locatelli, Franco .

EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2019, 15 (05) :497-509

[10] Determinants of CD19-positive vs CD19-negative relapse after tisagenlecleucel for B-cell acute lymphoblastic leukemia [J].

Dourthe, Marie-Emilie ;

Rabian, Florence ;

Yakouben, Karima ;

Chevillon, Florian ;

Cabannes-Hamy, Aurelie ;

Mechinaud, Francoise ;

Grain, Audrey ;

Chaillou, Delphine ;

Rahal, Ilhem ;

Caillat-Zucman, Sophie ;

Lesprit, Emmanuelle ;

Naudin, Jerome ;

Roupret-Serzec, Julie ;

Parquet, Nathalie ;

Brignier, Anne ;

Guerin-El Khourouj, Valerie ;

Lainey, Elodie ;

Caye-Eude, Aurelie ;

Cave, Helene ;

Clappier, Emmanuelle ;

Mathis, Stephanie ;

Azoulay, Elie ;

Dallel, Jean Hugues ;

Dhedin, Nathalie ;

Madelaine, Isabelle ;

Larghero, Jerome ;

Boissel, Nicolas ;

Baruchel, Andre .

LEUKEMIA, 2021, 35 (12) :3383-3393

← 1 2 3 →